| Field | Value |
|---|---|
| Company type | Applied AI (biological foundation models, therapeutics) |
| Founded | 2019, London |
| Headquarters | London, United Kingdom |
| Founders | Glen Gowers, Oliver Vince |
| Models | Eden family of biological foundation models |
| Total funding | $225 million (as of September 2026) |
Basecamp Research is a London-based company that trains biological foundation models, which it calls the Eden models, and applies them to the design of therapeutics. It states that the models are trained on the world's largest proprietary genomic dataset, collected through partnerships in more than 30 countries. Its first therapeutic focus is in vivo cell therapy, reprogramming a patient's cells inside the body (Source: tech.eu).
Snapshot
Funding
| Date | Round | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-09-23 | Series C | $140M (total raised $225M) | Led by S32; new investors Anthropic's Anthology Fund (with Menlo Ventures), Catalio, the NATO Innovation Fund, Rockefeller, European Tech Collective and the UK government's Sovereign AI Fund; returning investors NVentures (Nvidia), Firebrand, River Capital, King Philanthropies and Redalpine | (Source: tech.eu) |
Business and models
The company pairs its models' ability to design long and complex DNA sequences with enzymes that deliver them precisely, with the stated aim of making cell therapies more sophisticated, more customisable and simpler to administer than current therapies, which it says are limited in what they can deliver and by manufacturing that costs hundreds of thousands of dollars per patient. It says its pipeline of AI-designed therapeutics is advancing toward clinical development following preclinical results across multiple disease areas, and that the Series C will fund training a new generation of Eden models (Source: tech.eu).
History
Basecamp Research was founded in London in 2019 by Glen Gowers and Oliver Vince (Source: redalpine.com). The company traces its origins to the founders' doctoral work in synthetic biology and bioengineering and to a 2019 expedition to Iceland's Vatnajökull ice cap, where they set up an off-grid DNA sequencing operation (Source: tech.eu).
Relationships
- related: Anthropic — investor through the Anthology Fund (September 2026).
- related: Nvidia & TSMC — AI Compute Infrastructure — investor through NVentures.
- related: AI for Science — biological foundation models applied to therapeutic design.
- deploys-in: Healthcare — AI Deployment — AI-designed cell therapies in preclinical development.